First Time Loading...

Beijing Hotgen Biotech Co Ltd
SSE:688068

Watchlist Manager
Beijing Hotgen Biotech Co Ltd Logo
Beijing Hotgen Biotech Co Ltd
SSE:688068
Watchlist
Price: 29.75 CNY -0.83% Market Closed
Updated: May 15, 2024

Beijing Hotgen Biotech Co Ltd
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Beijing Hotgen Biotech Co Ltd
Gross Profit Peer Comparison

Comparables:
603259
300759
2269
300347
1548

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
Beijing Hotgen Biotech Co Ltd
SSE:688068
Gross Profit
¥331.4m
CAGR 3-Years
1%
CAGR 5-Years
19%
CAGR 10-Years
N/A
WuXi AppTec Co Ltd
SSE:603259
Gross Profit
¥15.8B
CAGR 3-Years
31%
CAGR 5-Years
32%
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Gross Profit
¥3.9B
CAGR 3-Years
23%
CAGR 5-Years
32%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Gross Profit
¥6.8B
CAGR 3-Years
39%
CAGR 5-Years
46%
CAGR 10-Years
N/A
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Gross Profit
¥2.7B
CAGR 3-Years
19%
CAGR 5-Years
21%
CAGR 10-Years
32%
Genscript Biotech Corp
HKEX:1548
Gross Profit
$409.6m
CAGR 3-Years
17%
CAGR 5-Years
21%
CAGR 10-Years
N/A

See Also

What is Beijing Hotgen Biotech Co Ltd's Gross Profit?
Gross Profit
331.4m CNY

Based on the financial report for Dec 31, 2023, Beijing Hotgen Biotech Co Ltd's Gross Profit amounts to 331.4m CNY.

What is Beijing Hotgen Biotech Co Ltd's Gross Profit growth rate?
Gross Profit CAGR 5Y
19%

Over the last year, the Gross Profit growth was -81%. The average annual Gross Profit growth rates for Beijing Hotgen Biotech Co Ltd have been 1% over the past three years , 19% over the past five years .